Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The compound 5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine is a synthetic chemical belonging to the quinazoline class of compounds. Quinazolines are medicinally important nitrogen heterocycles known for exhibiting diverse biological activities. Derivatives of quinazoline have been extensively studied for their potential as antibacterial, anticancer, and anti-inflammatory agents. While the broader class of quinazoline-2,4(1H,3H)-dione derivatives has shown antimicrobial activity and inhibition of human tumor cell lines, specific details regarding the mechanism of action, primary indication, or development status for this exact compound are not available in the provided search results.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine.